HER2 gene and protein expression status of breast carcinoma can be reliably tested on a single slide

Human epidermal growth factor receptor 2 (HER2) status in breast carcinomas serves as a predictor of benefit from anti-HER2 therapy. In providing clinicians with the information necessary to decide whether or not to treat with targeted therapy, it might be necessary to choose between methods assessi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chenard, Marie-Pierre, Wissler, Marie-Pierre, Weingertner, Noëlle, Mathelin, Carole, Bellocq, Jean-Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529453/
https://www.ncbi.nlm.nih.gov/pubmed/25985875
http://dx.doi.org/10.1007/s00428-015-1781-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529453/
https://www.ncbi.nlm.nih.gov/pubmed/25985875
http://dx.doi.org/10.1007/s00428-015-1781-0

Ejemplares similares